| pubmed-article:12437097 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12437097 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
| pubmed-article:12437097 | lifeskim:mentions | umls-concept:C1155065 | lld:lifeskim |
| pubmed-article:12437097 | lifeskim:mentions | umls-concept:C0081937 | lld:lifeskim |
| pubmed-article:12437097 | lifeskim:mentions | umls-concept:C0004368 | lld:lifeskim |
| pubmed-article:12437097 | lifeskim:mentions | umls-concept:C2267219 | lld:lifeskim |
| pubmed-article:12437097 | pubmed:dateCreated | 2002-11-19 | lld:pubmed |
| pubmed-article:12437097 | pubmed:abstractText | Activated T lymphocytes express high levels of dipeptidyl peptidase IV (DP IV)/CD26. Recent studies support the notion that DP IV may play an important role in the regulation of differentiation and growth of T lymphocytes. This article gives a short overview on DP IV/CD26 expression and effects on immune cells in vitro and in vivo. A major focus of this review are clinical aspects of the function of CD26 on hematopoietic cells and the potential usage of synthetic DP IV inhibitors as therapeutics in inflammatory disorders. | lld:pubmed |
| pubmed-article:12437097 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12437097 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12437097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12437097 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12437097 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12437097 | pubmed:author | pubmed-author:NeubertKlausK | lld:pubmed |
| pubmed-article:12437097 | pubmed:author | pubmed-author:ReinholdDirkD | lld:pubmed |
| pubmed-article:12437097 | pubmed:author | pubmed-author:KähneThiloT | lld:pubmed |
| pubmed-article:12437097 | pubmed:author | pubmed-author:AnsorgeSiegfr... | lld:pubmed |
| pubmed-article:12437097 | pubmed:author | pubmed-author:SteinbrecherA... | lld:pubmed |
| pubmed-article:12437097 | pubmed:author | pubmed-author:WrengerSabine... | lld:pubmed |
| pubmed-article:12437097 | pubmed:author | pubmed-author:BrockeStefanS | lld:pubmed |
| pubmed-article:12437097 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12437097 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12437097 | pubmed:pagination | 1133-8 | lld:pubmed |
| pubmed-article:12437097 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:12437097 | pubmed:articleTitle | The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity. | lld:pubmed |
| pubmed-article:12437097 | pubmed:affiliation | Institute of Immunology, Otto-von-Gueircke University Magdeburg, Germany. | lld:pubmed |
| entrez-gene:1803 | entrezgene:pubmed | pubmed-article:12437097 | lld:entrezgene |
| http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12437097 | lld:entrezgene |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12437097 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12437097 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12437097 | lld:pubmed |
